世界の胃がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Stomach Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4909 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、胃がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胃がん分子診断の市場動向 ・企業の競争状況、市場シェア ・胃がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・胃がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・胃がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・胃がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genetech、Amoydx、Sinomdgene、Genetronhealth、Premed、Berryoncology、Gene+、Helixgen、Annoroad、Topgen、Geneis） ・結論

A molecular approach for diagnosing stomach cancer

Market Analysis and Insights: Global Stomach Cancer Molecular Diagnostics Market
The global Stomach Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stomach Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stomach Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stomach Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stomach Cancer Molecular Diagnostics market.

Global Stomach Cancer Molecular Diagnostics Scope and Market Size
Stomach Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stomach Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genetech
Amoydx
Sinomdgene
Genetronhealth
Premed
Berryoncology
Gene+
Helixgen
Annoroad
Topgen
Geneis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Stomach Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Stomach Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Stomach Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Stomach Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stomach Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Stomach Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Stomach Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Stomach Cancer Molecular Diagnostics Market Trends
2.3.2 Stomach Cancer Molecular Diagnostics Market Drivers
2.3.3 Stomach Cancer Molecular Diagnostics Market Challenges
2.3.4 Stomach Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Stomach Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Stomach Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Stomach Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stomach Cancer Molecular Diagnostics Revenue
3.4 Global Stomach Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Stomach Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer Molecular Diagnostics Revenue in 2020
3.5 Stomach Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Stomach Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Stomach Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Stomach Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Stomach Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Stomach Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Stomach Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Stomach Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Stomach Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Stomach Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Stomach Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Stomach Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Stomach Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Stomach Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Stomach Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Stomach Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Stomach Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Stomach Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Stomach Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genetech
11.1.1 Genetech Company Details
11.1.2 Genetech Business Overview
11.1.3 Genetech Stomach Cancer Molecular Diagnostics Introduction
11.1.4 Genetech Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Genetech Recent Development
11.2 Amoydx
11.2.1 Amoydx Company Details
11.2.2 Amoydx Business Overview
11.2.3 Amoydx Stomach Cancer Molecular Diagnostics Introduction
11.2.4 Amoydx Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Amoydx Recent Development
11.3 Sinomdgene
11.3.1 Sinomdgene Company Details
11.3.2 Sinomdgene Business Overview
11.3.3 Sinomdgene Stomach Cancer Molecular Diagnostics Introduction
11.3.4 Sinomdgene Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Sinomdgene Recent Development
11.4 Genetronhealth
11.4.1 Genetronhealth Company Details
11.4.2 Genetronhealth Business Overview
11.4.3 Genetronhealth Stomach Cancer Molecular Diagnostics Introduction
11.4.4 Genetronhealth Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Genetronhealth Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Stomach Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Stomach Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Berryoncology Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Stomach Cancer Molecular Diagnostics Introduction
11.7.4 Gene+ Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Gene+ Recent Development
11.8 Helixgen
11.8.1 Helixgen Company Details
11.8.2 Helixgen Business Overview
11.8.3 Helixgen Stomach Cancer Molecular Diagnostics Introduction
11.8.4 Helixgen Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Helixgen Recent Development
11.9 Annoroad
11.9.1 Annoroad Company Details
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Stomach Cancer Molecular Diagnostics Introduction
11.9.4 Annoroad Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Annoroad Recent Development
11.10 Topgen
11.10.1 Topgen Company Details
11.10.2 Topgen Business Overview
11.10.3 Topgen Stomach Cancer Molecular Diagnostics Introduction
11.10.4 Topgen Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Topgen Recent Development
11.11 Geneis
11.11.1 Geneis Company Details
11.11.2 Geneis Business Overview
11.11.3 Geneis Stomach Cancer Molecular Diagnostics Introduction
11.11.4 Geneis Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Geneis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Stomach Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Stomach Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Stomach Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Stomach Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Stomach Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Stomach Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Stomach Cancer Molecular Diagnostics Market Trends
Table 13. Stomach Cancer Molecular Diagnostics Market Drivers
Table 14. Stomach Cancer Molecular Diagnostics Market Challenges
Table 15. Stomach Cancer Molecular Diagnostics Market Restraints
Table 16. Global Stomach Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Stomach Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Stomach Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Stomach Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Stomach Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Stomach Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Stomach Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Stomach Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Stomach Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Genetech Company Details
Table 64. Genetech Business Overview
Table 65. Genetech Stomach Cancer Molecular Diagnostics Product
Table 66. Genetech Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Genetech Recent Development
Table 68. Amoydx Company Details
Table 69. Amoydx Business Overview
Table 70. Amoydx Stomach Cancer Molecular Diagnostics Product
Table 71. Amoydx Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Amoydx Recent Development
Table 73. Sinomdgene Company Details
Table 74. Sinomdgene Business Overview
Table 75. Sinomdgene Stomach Cancer Molecular Diagnostics Product
Table 76. Sinomdgene Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Sinomdgene Recent Development
Table 78. Genetronhealth Company Details
Table 79. Genetronhealth Business Overview
Table 80. Genetronhealth Stomach Cancer Molecular Diagnostics Product
Table 81. Genetronhealth Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Genetronhealth Recent Development
Table 83. Premed Company Details
Table 84. Premed Business Overview
Table 85. Premed Stomach Cancer Molecular Diagnostics Product
Table 86. Premed Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Premed Recent Development
Table 88. Berryoncology Company Details
Table 89. Berryoncology Business Overview
Table 90. Berryoncology Stomach Cancer Molecular Diagnostics Product
Table 91. Berryoncology Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Berryoncology Recent Development
Table 93. Gene+ Company Details
Table 94. Gene+ Business Overview
Table 95. Gene+ Stomach Cancer Molecular Diagnostics Product
Table 96. Gene+ Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Gene+ Recent Development
Table 98. Helixgen Company Details
Table 99. Helixgen Business Overview
Table 100. Helixgen Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Helixgen Recent Development
Table 102. Annoroad Company Details
Table 103. Annoroad Business Overview
Table 104. Annoroad Stomach Cancer Molecular Diagnostics Product
Table 105. Annoroad Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Annoroad Recent Development
Table 107. Topgen Company Details
Table 108. Topgen Business Overview
Table 109. Topgen Stomach Cancer Molecular Diagnostics Product
Table 110. Topgen Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Topgen Recent Development
Table 112. Geneis Company Details
Table 113. Geneis Business Overview
Table 114. Geneis Stomach Cancer Molecular Diagnostics Product
Table 115. Geneis Revenue in Stomach Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Geneis Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stomach Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Stomach Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Stomach Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Stomach Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Stomach Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Stomach Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Stomach Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Stomach Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Stomach Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Stomach Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Stomach Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Stomach Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Stomach Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Stomach Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Stomach Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Stomach Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Stomach Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Stomach Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Stomach Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Stomach Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Stomach Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Stomach Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Stomach Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genetech Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Amoydx Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Sinomdgene Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Genetronhealth Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Premed Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Berryoncology Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Gene+ Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Helixgen Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Annoroad Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Topgen Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Geneis Revenue Growth Rate in Stomach Cancer Molecular Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---